Proposed causes of eGFR difference did not account for its association with adverse outcomes in CKD. A study examined patients at two Danish hospitals receiving a shared decision-making and dialysis choice intervention. A population health management intervention for CKD lowered hospitalization rates but not costs. An AI-based gout management system was associated with better serum urate and CKD outcomes in a recent study. "Nudge" letters to patients and practices were not effective at increasing uptake of RASi or SGLT2i for CKD management. Dialysis is not right for all patients. Here's what to consider when weighing dialysis vs conservative kidney management. Dialysis facilities with more commercially insured patients beat mortality rates of those serving more Medicare patients. Dietitian Jessica Strawn helps bust some common nutrition myths for patients with CKD. A literature review showed a significant increase in hyperkalemia among patients with CKD despite treatment with RAASi. Research revealed an association between social isolation and the onset of CVD and accelerated death in CKD. A study found that primary care physician-nephrologist collaboration did not improve kidney or CV outcomes in stage 5 CKD. A study showed similar efficacy and cardiovascular safety between vadadustat and darbepoetin alfa for anemia with CKD. This NephJC RoboPod episode discusses the NUDGE trial of electronic nudges to increase CKD guideline-directed therapy. Editorial board chair Dr. Ajay Singh discusses how GFR may vary between sexes and affect rates of CKD. Elevated glucose uptake in adipose tissue of patients with gout may contribute to CKD progression. Use of SGLT2i with RAASi is associated with reduced risk for hyperkalemia in the clinical setting, a study found. Kidney Care Partners visited called on Congress to support policies benefitting Americans with kidney disease. AstraZeneca and Aptar Digital Health are partnering on screening algorithms to detect CKD and other conditions. Variability in eGFR over time is associated with risks of cardiovascular and kidney outcomes and mortality in those with CKD. An observational study shed light on how family medical history may affect chronic kidney disease (CKD) outcomes.